Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01654224 · ClinicalTrials.gov registry record · Phase 4
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 205
- Enrollment target
NCT01654224 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 205 participants.
The verdict
NCT01654224, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 205 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the performance of two currently available influenza (flu) vaccines. This study will try and determine if the high dose flu vaccine provides protection that is the same or better than that of regular dose flu vaccine. Both the regular dose and the high dose flu vaccines are approved by the FDA for use in older adults.
Interventions
- BIOLOGICAL High Dose Inactivated Influenza Vaccine
- BIOLOGICAL Standard Dose Inactivated Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01654224
The ClinicalTrials.gov registry entry for NCT01654224 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Dose Inactivated Influenza Vaccine is the first listed.
NCT01654224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01654224 about?
NCT01654224 is a clinical study titled "Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting". The purpose of the study is to compare the performance of two currently available influenza (flu) vaccines. This study will try and determine if the high dose flu vaccine provides protection that is the same or better than that of regular dose flu vaccine. Both the regular dose and the high dose flu...
What is the current status of trial NCT01654224?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 205 participants. The study started on 2011-11. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01654224?
The interventions under investigation include: High Dose Inactivated Influenza Vaccine (BIOLOGICAL), Standard Dose Inactivated Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01654224?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.